Softwr

Research · head to head

Genedata vs NVivo

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
NVivo logo

NVivo

Research

Easy-to-use, collaborative qualitative analysis software

From
On request
Rated
-

The short version

  • Each has a real cost: Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.; NVivo base plan pricing not displayed on shop page; requires adding to cart or contacting sales
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Genedata and NVivo actually diverge.

Attributes where Genedata and NVivo differ
AttributeGenedataNVivo
PlatformsWeb, On-premise, Private cloudWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

Only in NVivo

Nothing recorded that Genedata does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot NVivo
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot NVivo
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot NVivo
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot NVivo

NVivo

  • Qualitative data analysis for researchnot Genedata
  • Document and interview coding and analysisnot Genedata
  • Transcription and collaborative research projectsnot Genedata

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

NVivo

  • Base plan pricing not displayed on shop page; requires adding to cart or contacting sales
  • Volume licensing (10+ seats) requires sales contact only
  • No free version available, only trials without specified duration

Pricing, plan by plan

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

NVivo

On request

No published plan breakdown. See the NVivo review.

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.

Choose NVivo if

Nothing in the data separates NVivo from Genedata on the points above - pick on price and on how each one feels to use.

Questions people ask

Is Genedata or NVivo better?
Neither clearly leads. Genedata starts at On request and NVivo at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or NVivo?
Genedata starts at On request and NVivo at On request.
Does Genedata or NVivo run on more platforms?
Genedata runs on Web, On-premise, Private cloud. NVivo runs on Web.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what NVivo is typically brought in for.
What can Genedata do that NVivo cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

NVivo: How much does NVivo cost?

NVivo pricing is not displayed on the public website. Base plan pricing varies by subscription type and region. Individual/small teams can purchase directly through shop.lumivero.com, while organizations with 10+ licenses must contact sales for quotes.

Source
Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

NVivo: What are NVivo add-on costs?

NVivo AI Assistant costs $250 per year. Transcription costs $499 per year (50 hours annually) or $30 one-time (60 minutes). Collaboration Cloud for team sharing costs $99 per year.

Source
Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

NVivo: Does NVivo offer a free version?

No free version of NVivo is available. Free trials are available at the product website, though trial duration is not specified. Individual users can purchase licenses directly through lumivero.com.

Source
Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

NVivo: Is NVivo AI Assistant included in subscription?

No, NVivo AI Assistant is a paid add-on costing $250 per year. However, through August 18-September 15, 2026, AI Assistant is free with annual NVivo + AI subscriptions using code BTSAI100.

Source
Share

Related pages

Other head to heads